Clinical Trials Logo

Clinical Trial Summary

The aim of the study is to define preferential sites of tumour recurrence by observing tracer uptake in the tumour in sequential PET images with 18F-fluoromethylcholine (and perfusion MR, see also below). Changes in the intensity of the tracer uptake in the tumour during and after the course of radiotherapy will be correlated with the site of tumour recurrence as will be assessed by conventional MRI. In due time, these results must enable clinicians to change their therapeutic approach of high-grade glioma.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT00628940
Study type Interventional
Source University Ghent
Contact
Status Completed
Phase Phase 1
Start date January 12, 2010
Completion date March 22, 2018